Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer
Karen S. Anderson(Institute for Biodiversity), M. Posner(Icahn School of Medicine at Mount Sinai), Gypsyamber DʼSouza(Johns Hopkins University), Joshua LaBaer(Arizona State University), Karl T. Kelsey(Brown University), Jochen H. Lorch(Northwestern University), Janina A. Longtine(Boston Children's Hospital), Robert I. Haddad(Georgetown University), Angelika B. Riemer(German Cancer Research Center), M.D. McClean(Boston University), Sara I. Pai(Yale University), Jennifer S. Wong
Cited by 69
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
|Immunity|2018|937
The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
|Journal of Clinical Investigation|2011|928